Finally, the negative regulator of the immune-calming TGF-β, mothers against decapentaplegic homolog 7 (SMAD7), is increased in IBD [246], thereby blocking one counterregulatory measure to the excessive inflammation induced by these cytokines. Here, SMAD7 is linked to inflammatory bowel disease.